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Abstract
Aims. To do a genome-wide gene expression study of active and inactive ulcerative colitis and Crohn’s disease (inﬂammatory
bowel disease – IBD) and examine the most differentially expressed genes. As the study showed an extreme upregulation of all
regenerating islet-derived genes (REG proteins) in active IBD, we further studied the expression of REGs on protein level in
active and inactive IBD, as well as in non-IBD (pseudomembranous) colitis. Methods. Microarray analysis was done on a total
of 100 pinch biopsy samples from healthy controls and patients with Crohn’s disease or ulcerative colitis. Tissue samples from
IBD and pseudomembranous colitis were examined with routine histology and immunohistochemical analysis for REGIa,
REGIV, DEFA6, and serotonin. Results. REG mRNAs were up to 83 times overexpressed in diseased mucosa compared with
mucosa from healthy individuals. REGIa and REGIV were overexpressed at immunohistochemistry and located to different
mucosal cell types. REGIa was expressed in basal half of crypts, REGIV in mid and outer parts of crypts and in surface
epithelium and seems to be stored in, and secreted from, goblets. Pseudomembranous colitis samples showed similar staining
patterns, and some IBD samples stained REG positive without inﬂammation on routine histology. Conclusions. All REG
family mRNAs are upregulated in IBD. REGIa and REGIV have different cellular localization, possibly reﬂecting different
biological functions. REG protein expression also in pseudomembranous colitis shows that REG family proteins are regulated
in inﬂammatory injury and repair, not speciﬁcally for IBD as previously thought.
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Introduction
Regenerating gene (REG) family proteins are struc-
turally similar proteins belonging to the calcium-
dependent (C-type) lectin gene superfamily. In
humans, the family has four known members;
REGIa, REGIb, REGIII, and REGIV. The ﬁrst
REG protein was discovered in regenerating pancre-
atic islets in rats [1], and REG proteins have since
been found involved in other physiological and path-
ophysiological processes [2]. Their basic biological
effects seem to be induction of cellular proliferation
and inhibition of apoptosis. REGIa seems to have a
physiological role in the gastric mucosa, related to the
general trophic effect of gastrin on the gastric oxyntic
mucosa [3]. Elsewhere in the gastrointestinal system,
these proteins are found during tissue injury and
neoplasia. They are overexpressed in gastric and colo-
rectal cancers [4], and in colorectal cancer cell lines
[5]. Lawrance et al. [6] ﬁrst showed overexpression of
REGIa and REGIb mRNA in resected colonic tissue
from both Crohn’s disease (CD) and ulcerative colitis
(UC). Subsequent studies have found that REGIa,
REGIb and REGIII mRNAs are overexpressed in the
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that REGIa is overexpressed in CD [9]. Sekikawa
et al. found that REGIa mRNA and protein are
overexpressed in UC [10], in particular in dysplasia
or cancer, and a more recent study also shows a
possible role for REG1a as a marker for UC associ-
ated neoplasia [11]. Very recent studies indicate a
mechanism for IL-22 stimulated expression of
REG1a through the IL-22R1 receptor [12].
In a microarray-based genome-wide gene expres-
sion study on CD and UC performed in our labora-
tory (unpublished), genes coding for REG family
proteins and for Paneth-cell-speciﬁc defensins con-
stituted six of the seven top genes on the list of
differentially expressed genes in active CD. REG
genes were up to 83 times overexpressed on
mRNA level compared with tissue from healthy indi-
viduals. This ﬁnding prompted us to carry out a
systematic study on the expression of all REG classes
in affected and unaffected mucosa from patients with
IBD. The expression of REGIa and REGIV was
further investigated using immunohistochemistry
(IHC). Since IBD speciﬁcity of REG gene induction
is assumed but not proven, we also included an
immunohistochemical analysis of REG proteins in
pseudomembranous colitis (PC). This work thus
describes the expression of REGIa, REGIb, REGIIIb
and REGIV on mRNA level, and REGIa and REGIV
proteins by IHC. Cellular localization of REGIa is
studied by co-staining for the Paneth-cell-speciﬁc
defensin alpha 6 (DEFA6), and of REGIV by co-




Patients admitted to the Gastrointestinal Endoscopy
Unit, Department of Gastroenterology, St. Olav’s
University Hospital, for colonoscopy were included
after informed consent. The patients had CD or
ulcerative colitis/proctitis (UC/UP), or underwent
colonoscopy due to gastrointestinal symptoms. The
UC group also included six patients with an associ-
ated diagnosis of primary sclerosing cholangitis
(PSC). Normal controls were deﬁned by clinically
indicated examinations ﬁnding no signs of gastroin-
testinal disease. Endoscopic biopsies were taken from
macroscopically maximally inﬂamed mucosa, span-
ning the whole colon from rectum to ascending colon,
and macroscopically normal tissue always from the
hepatic ﬂexure. Four adjacent biopsies taken from
each location were either immediately snap frozen and
stored on liquid nitrogen, or ﬁxed on 4% buffered
formaldehyde. For the IHC analysis, biopsies taken
from patients with UP and antibiotic-induced PC
were also included in the study. The Regional Med-
ical Research Ethics Committee approved the study
(no 5.2007.910), which was registered in the Clin-
icalTrials Protocol Registration System (identiﬁer
NCT00516776).
Microarray analysis
The microarray analysis included a total of 100 sam-
ples, representing CD diseased/normal (7/19), UC
diseased/normal (24/31), and normal controls (19).
Frozen biopsies were homogenized and total RNA
extracted using the Ambion mirVana
  miRNA Iso-
lation Kit (Applied Biosystems, CA, USA). RNA
quality was determined using NanoDrop
  Spectro-
photometer (Thermo Scientiﬁc, DE, USA) and Bio-
analyzer (Agilent Technologies, CA, USA). All
samples used were of high quality (Rin value >7).
Microarray analysis followed standard protocols,
using Illumina human HT-12 expression BeadChips
(Illumina, San Diego, CA, USA) and an Illumina
BeadStation.
The R software environment and the Bioconductor
package were used for the analysis of the Illumina data
[13]. Differential expression was assessed using linear
models with least squares regression and empirical
Bayes moderated t-statistics [14]. p Values were
adjusted for multiple comparisons using Benjamini–
Hochberg false discovery rate correction.
Real-time RT-PCR
From the seven top differentially expressed genes
(Table I), these six were veriﬁed by real-time RT-
PCR: REGIa, REGIb, REGIIIb, REGIV, DEFA5,
and DEFA6. Seven samples were randomly selected
from each of ﬁve groups: CD (diseased and unaf-
fected mucosa), UC (diseased and unaffected
mucosa), and healthy individuals. Primer sequences
(RefSeq Build 36.1) are given in Table II. The iScript
cDNA synthesis kit (Bio-Rad, Hercules, CA, USA)
was used to prepare cDNA, and real-time RT-PCR
performed using a FastStart SYBR Green Master mix
(Roche Diagnostics, Basel, Switzerland). Reference
gene was b-actin (ACTB). PCRs were run in triplicate
on an MX3000P
  System (Stratagene, La Jolla, CA,
USA). The DD-Ct method was used [15] to analyze
PCR data.
Expression levels for unaffected and affected
mucosa in UC or CD were compared with normal
controls, using one-way ANOVA with Dunnett’s post
test. Statistical analyses were done and graphs
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Windows (GraphPad Software, San Diego, CA,
USA).
Histological and immunohistochemical examinations
Formaldehyde-ﬁxed samples were embedded in par-
afﬁn, and 4-mm sections were cut and stained with
hematoxylin–eosin (H–E) for histological evaluation
by an experienced pathologist to assess inﬂammation.
Biopsies used for immunohistochemical analysis were
taken adjacent to those for gene expression analysis.
Biopsies from PC were archival material; otherwise
the biopsies were handled as for those in the IBD
groups.
These commercially available antibodies were used:
REGIa – polyclonal rabbit antibody (Cat No
RD181078100, BioVendor, Midrice, Czech Repub-
lic, dilution 1:500), REGIV – polyclonal goat anti-
body (Cat No AF1379, R&D Systems, Minneapolis,
MN, USA, dilution 1:400), DEFA6 – polyclonal
rabbit antibody (Cat no HPA019462, Sigma, St.
Louis, MO, dilution 1:1000), and serotonin – mono-
clonal mouse antibody (Cat no AB16007, Abcam plc,
Cambridge, UK). REGIa DEFA6 and serotonin
were detected with the Dako EnVision peroxidase
kit (Dako, Glostrup, Denmark) and REGIV with
the Vectastain ABC kit (Vector Laboratories,
Burlingame, CA, USA), all combined with Dako
DAB+ as chromogen. Sections were counterstained
with hematoxylin. Serial (neighboring) sections were
made to assess co-localization of REGIa and DEFA6,
or REGIV and serotonin. A comprehensive study of
REGIa protein expression was performed on a total of
147 samples, including samples from UC diseased/
normal (32/34) (including 4/5 patients with associated
PSC diagnosis), CD diseased/normal (12/21), UP
diseased/normal (11/13), and normal controls (23).
Results
Patients and biopsy specimens
Among the UC patients, 12 were using corticoster-
oids and 42 were using 5-aminosalicylic preparations,
among the CD patients 6 and 5, respectively. All data
were thoroughly assessed for correlation between
medication and REG gene or protein expression.
No such correlation was found. No patients used
immunomodulants such as azathioprine or metho-
trexate, or TNFa blockers. Six patients were
excluded due to a clinicopathological diagnosis of
indeterminate colitis.
Microarray and real-time RT-PCR analysis
Contrasting diseased CD or diseased UC against
normal controls (CDD/N or UCD/N) generated lists
of differentially expressed genes. Controlling the false
discovery rate at 0.05, the number of signiﬁcant genes
was 4201 and 6935, respectively. The top genes when
sorted according to gene expression ratio are shown
in Table I. Gene expression levels were all signiﬁ-
cantly different from controls, adjusted p values rang-
ing from 2.8  10
-10 to 3.5  10
-6. RT-PCR analysis
conﬁrmed the ﬁndings from microarray, mean gene
expression ratio (log2) between diseased tissues versus
normal controls varying from 3.8 for DEFA5 expres-
sion in UCD versus N to 11.7 for REGIb expression
in CDD versus N.
Table I. Microarray gene expression results – top 7 genes CDD/N.
Gene
CDD/N (ratio
given as log2)N o – CDD
UCD/N (ratio
given as log2)N o – UCD
REGIa 6,38 1 5,34 1
REGIb 6,33 2 5,26 2
REGIIIa 6,14 3 4,58 4
DEFA6 5,45 4 2,89 29
DEFA5 5,29 5 2,80 30
LCN2 3,76 6 3,99 9
REGIV 3,73 7 3,48 13
UCD = diseased ulcerative colitis, CDD = diseased Crohn’s dis-
ease, N = healthy controls. No – CDD = gene expression rank
number on CDD prioritized list, No – UCD = gene expression rank
number on UCD prioritized list.
Table II. Primer sequences for real-time RT-PCR veriﬁcation of microarray results.
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Normal colonic mucosa had no REGIa immunore-
activity (Figure 1A). In patients with CD and UC
biopsies from mucosa histologically assessed as nor-
mal, immunoreactivity for REGIa ranged from neg-
ative to moderate positively stained crypt epithelium
(Figure 2A–D). The staining pattern for PC samples
(Figure 3A) was similar. Diseased mucosa from all
patient groups revealed strong REGIa immunostain-
ing in cytoplasm of crypt cells whereas surface epi-
thelium was negative (Figure 2D (insert)).
DEFA6 immunoreactive epithelial cells were local-
ized in the basal parts of the crypts. REGIa was
expressed in both Paneth cells and crypt epithelium,
in Paneth cells at a higher level (Figure 2G–H). The
results from REGIa immunostaining of the extended
set of samples are shown in Table III.
A correlation analysis investigating the relationship
between REGIa gene expression detected in micro-
array analysis and REGIa protein expression
observed during IHC showed a signiﬁcant correla-
tion, with a squared correlation coefﬁcient (R
2)o f
0.76 and p value < 0.0001. A plot of the correlation
with the regression line ﬁtted is shown in Figure 4.
Slight REGIV immunoreactivity was observed in
crypts and surface epithelium of all control biopsies
(Figure 1B). Biopsies from IBD cases assessed as
normal revealed negative to weakly positive immu-
noreactivity (Figure 5A–D), often exceeding that of
controls. Inﬂamed mucosal biopsies from both IBD
(Figure 5E and F) and PC (Figure 3B) showed
moderate to strong REGIV immunostaining with
similar histological distribution. In goblet cells,
immunoreactivity was localized to the mucin contents
and excreted material (Figure 5D (insert)). Addition-
ally, REGIV immunoreactivity was found in both
healthy and diseased individuals in cells that
co-stained for serotonin (Figure 5G–H), indicating
that these were enterochromafﬁnc e l l s .T h i s
co-staining pattern was similar in healthy individuals
and in normal and inﬂamed mucosa of IBD and
PC patients.
Discussion
This study shows a massive overexpression of REG
family mRNAs in diseased colonic mucosa with CD
or UC. As there are no commercially available
Table III. Summary of results from immunohistochemical evaluation of REGIa levels in biopsies.
Sample Group Number of samples
IHC evaluated REGIa level
Mean REGIa level
Different from
normal group (p value) P0123
N 23 1 22 0 0 0 0.0 –
CDN 21 5 14 0 1 1 0.4 NS
UCN 34 4 27 1 1 1 0.2 NS
UPN 13 3 10 0 0 0 0.1 NS
CDD 12 1 3 1 5 2 1.5 <0.01
UCD 32 2 5 5 13 8 1.7 <0.01
UPD 11 0 2 4 3 2 1.4 <0.01
N = healthy controls; CDN, UCN, or UPN = histologically normal mucosa from patients with known Crohn’s disease, ulcerative colitis, or
ulcerative proctitis; CDD, UCD, or UPD – histologically diseased mucosa from patients with Crohn’s disease, ulcerative colitis, or ulcerative
proctitis.
REGIa expression level: “P”: only Paneth cells were stained, “0” to “3”: an increasing level of staining. 0: No staining; 1: <20% of crypt
epithelial cells stained; 2: 20–50% of crypt epithelial cells stained; 3: >50% of crypt epithelial cells stained. Difference from normal group is
evaluated using two-tailed Welch t-test and result given as the p value for this test.
AB
Figure 1. Representative samples with immunohistochemistry for REGIa (A) and REGIV (B) in control colonic biopsies from healthy
individuals. REGIa staining is absent; REGIV shows slight staining in crypt and superﬁcial mucosal cells.
Activation of REG family in colitis 1319antibodies for REGIb and REGIIIa, only REGIa and
REGIV were also studied by IHC. For these two
REGs, the overexpression of REG mRNAs was con-
ﬁrmed on protein level, with strong staining for
REGIa and REGIV in all cases of active IBD. Cor-
relation analysis showed a strong correlation between
microarray measurement and IHC evaluation of
REGIa, indicating that the mRNA levels indeed
reﬂect protein levels. Samples from healthy indivi-
duals were negative for REGIa, but had a slight
background staining for REGIV. A corresponding





Figure 2. (A)/(B): Immunohistochemistry (IHC) for REGIa in non-inﬂamed mucosa from patients with known Crohn’s disease (CD)
(panel A, negative immunostaining; B, positive). (C)/(D): REGIa in non-inﬂamed mucosa from patients with ulcerative colitis (UC) (panel C,
negative immunostaining; D, positive). Insert C shows negative staining in non-inﬂamed mucosa and insert D shows REGIa in cytoplasma of
goblet cells but no staining inside gobletseF: Positive IHC for REGIa in inﬂamed mucosa from patients with CD (E) and UC (F). (G)/(H):
Basal colonic crypts from non-diseased mucosa in ulcerative colitis stained for REGIa (G) or DEFA6 (H). Crypt epithelial cells show a general
cytoplasmic staining for REGIa, and REGIa staining is clearly stronger in the DEFA6-positive Paneth cells.
1320 A. V. B. Granlund et al.samples from patients with known IBD but no inﬂam-
mation on routine histology and in non-IBD colitis
samples. These ﬁndings have not been reported
previously.
The cellular localization of REGIa and REGIV is
different. REGIa positivity is seen in basal crypt cells,
REGIV mainly in the mid-gland areas. REGIa was
located to the cytoplasm, increasing during inﬂam-
mation. Cytoplasmic REGIV was not clearly different
between biopsies from healthy individuals, active IBD
or inactive IBD. However, REGIV was clearly
increased in goblets in active disease and seemed to
be secreted with the mucus. The observation that
REGIV is located to goblets corresponds to previous
ﬁndings by Kamarainen and coworkers [16], and a
recent study on appendiceal mucinous cystadenoma
and pseudomyxoma peritonei [17] also found REGIV
in goblets and mucus. This suggests that REGIV is
secreted and may have a luminal mode of action.
Additionally, REGIV is clearly localized to
serotonin-positive enteroendocrine cells of the colon
as has previously been observed in the upper GI tract
and in the ileum [16]. This is of potential interest
since serotonin seems to have an unclariﬁed role in
IBD [18]. At least one study suggests that REGIa is
found solely in Paneth cells [8]. In our study, REGIa
is found in both Paneth and goblet cells and Paneth
cells staining stronger than other crypt cells. Thus,
both Paneth and goblet cells express REGIa but at a
higher level in Paneth cells. Interestingly, REGIa
staining is seen in some cases with CD or UC, where
routine histological examination concluded with nor-
mal colonic mucosa. The positivity was mainly seen in
Paneth cells, but in a few cases also in other cells of the
epithelium (see Table III for details). This suggests
that REGIa IHC could aid in the diagnosis of IBD
when biopsies are taken in the quiescent phase of the
diseases.
REG proteins are antiapoptotic and stimulate pro-
liferation and repair [2], and apparently have roles in
the trophic response to gastrin and in colorectal
cancer. This indicates that REG proteins are involved
in injury, repair, and growth on a general level. This
assumption is supported by a REGIa expression
pattern in pseudomembranous colitis indistinguish-
able from that in IBD samples. It is possible that
REGIV has functions distinct from other REG pro-
teins. It is less regulated than any other REG mRNA
species in IBD; it is localized to another population of
epithelial cells and is also found in enteroendocrine
cells. Contrary to REGIa this protein seems to be
constitutively expressed, at least in serotonin-
positive enteroendocrine cells. Another highly inter-
esting aspect of REG proteins in the gut is that
RegIIIg in the mouse and its human ortholog
REGIIIa are considered to be antimicrobial peptides
with a lectin-like mode of action [19]. There are no
reports of this function for other REG proteins, but
with REGIV seemingly being excreted to the lumen,
further studies on the antimicrobial effects of REG
proteins are certainly warranted.
This is the ﬁrst study with a comprehensive eval-
uation of REG proteins in IBD, which also includes
non-diseased IBD samples and a non-IBD inﬂam-
matory disease of the colon. We conclude that REG
family proteins are strongly regulated in IBD and
most likely involved in injury and repair. At least
A B
Figure 3. Immunohistochemistry for REGIa (A) and REGIV (B) in mucosa from patients with known pseudomembranous colitis. Positive
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Figure 4. Correlation plot of REGIa mRNA levels measured using
microarray and REGIa staining levels observed using immunohis-
tochemistry (IHC; as given in Table III). Correlation analysis
showed a strong correlation with squared correlation coefﬁcient
(R
2) of 0.76 and p value < 0.0001.
Activation of REG family in colitis 1321one protein in the family, REGIV, may have a topical
mode of action and be involved in the enteroendo-
crine aspect of IBD pathophysiology. The REG pro-
tein response is not speciﬁc for IBD, but can be found
also in pseudomembranous colitis. Finally, REGIa is
a hitherto unrecognized and possibly useful and sen-
sitive marker for mucosal injury and repair.
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